Improving Fmoc Solid Phase Synthesis of Human Beta Defensin 3

Aleksandra Walewska1, Paulina Kosikowska-Adamus1, Marta Tomczykowska1

  • 1Department of Organic Chemistry, Faculty of Chemistry, University of Gdansk, 80-308 Gdansk, Poland.

Insights

We optimized the synthesis of human β-defensin 3 (HBD-3), a key antimicrobial peptide. This improved method facilitates further research into HBD-3

Area of Science:

  • Biochemistry
  • Immunology
  • Peptide Synthesis

Background:

  • Human β-defensin 3 (HBD-3) is a crucial antimicrobial and immunomodulatory peptide involved in host defense.
  • HBD-3 interacts with cell membranes and acts as a ligand for various receptors, including melanocortin and cytokine receptors, and voltage-gated potassium channels.
  • Previous structural and functional studies of HBD-3 were limited by inefficient synthetic and recombinant expression methods.

Purpose of the Study:

  • To develop an optimized Fmoc solid-phase synthesis strategy for human β-defensin 3 (HBD-3).
  • To improve the efficiency and yield of HBD-3 peptide synthesis.
  • To explore alternative disulfide bond formation strategies, including the use of diselenide bonds, to enhance oxidative folding.

Main Methods:

  • Utilized optimized resin, coupling reagents, and pseudoproline dipeptide building blocks for Fmoc solid-phase synthesis.
  • Employed an orthogonal disulfide bond formation strategy.
  • Investigated the replacement of a native disulfide bridge with a diselenide bond for improved oxidative folding.

Main Results:

  • The optimized synthesis significantly decreased chain aggregation and improved the yield of the target HBD-3 peptide.
  • The use of pseudoproline dipeptide building blocks enhanced the efficiency of the synthesis.
  • Replacing a native disulfide bridge with a diselenide bond improved the oxidative folding process.

Conclusions:

  • The developed optimized Fmoc solid-phase synthesis method enhances the efficiency and yield of HBD-3 production.
  • The alternative synthesis using a diselenide bond offers improved oxidative folding.
  • These advancements enable comprehensive biological and pharmacological characterization of HBD-3, advancing its therapeutic potential.

Related Concept Videos